21.26USD-0.93%Mkt Cap: 1.58B USDP/E: 3.43Last update: 2026-06-01
Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.58B USD
Enterprise Value1.30B USD
Revenue (TTM)420.69M USD
Gross Profit333.94M USD
Net Income (TTM)271.17M USD
Revenue/Share5.988 USD
Last Price21.26 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees159
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45781M1018
Valuation
P/E (Trailing)3.43
P/E (Forward)9.69
PEG0.33
EV/EBITDA6.75
EV/Revenue3.09
P/S3.76
P/B1.18
EPS (TTM)6.26
EPS (Forward)2.21
52W Range
16.5255% of range25.15
52W High25.15 USD
52W Low16.52 USD
Profitability
Gross Margin81.19%
Oper. Margin40.11%
EBITDA Margin45.81%
Profit Margin65.92%
ROE23.12%
ROA16.58%
Growth
Revenue Growth10.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF196.93M USD
CapEx (TTM)10.50M USD
FCF Margin25.00%
FCF Yield6.64%
Net Debt-280.51M USD
Net Debt/EBITDA-1.46
Balance Sheet
Debt/Equity0.23
Current Ratio21.13
Quick Ratio19.27
Book Value/Sh18.18 USD
Cash/Share8.291 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 8, 2015
Pay DateSep 30, 2015
Splits
Last Split1241:1000
Split DateJun 3, 2014
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)35.50 USD
Target Range18.00 USD – 46.00 USD
# Analysts4
Ownership
Shares Out.73.81M
Float69.07M
Insiders0.99%
Institutions107.86%
Short Interest
Short Ratio10.4d
Short % Float11.68%
Short % Out.8.67%
Shares Short6.40M
Short (prev mo.)6.73M
Technical
SMA 5022.93 (-7.3%)
SMA 20020.91 (+1.7%)
Beta0.38
S&P 52W Chg27.94%
Avg Vol (30d)641.63K
Avg Vol (10d)914.73K
Technical Indicators
RSI (14)37.1
MACD-0.3035
MACD Signal-0.2378
MACD Hist.-0.0658
BB Upper23.45 USD
BB Middle22.45 USD
BB Lower21.46 USD
BB Width8.87%
ATR (14)0.6496 USD
Vol Ratio (20d)0.72x